LG Chem (051910) Q1 2025 earnings summary

Executive summary

• Q1 2025 saw a challenging business environment with market downturns and geopolitical volatility, but profitability improved quarter-over-quarter due to cost-cutting, increased sales of high-value-added products, and a rebound in operating profit to KRW 447 billion (3.7% OPM) after a prior loss.

• Net income was KRW 260 billion, recovering from a net loss of KRW 899 billion in 4Q 2024.

• EBITDA improved to KRW 1,733 billion (14.2% margin), up from KRW 1,027 billion in the previous quarter.

• Strategic focus remains on operational optimization, business restructuring, and developing new growth drivers to address ongoing uncertainties.

Financial highlights

• Consolidated Q1 sales were KRW 12,171 billion, a 4.8% increase sequentially from 4Q 2024.

• Operating profit reached KRW 447 billion (OP margin 3.7%), and net profit was KRW 260 billion.

• Gross profit margin rose to 16.8% from 11.9% in 4Q 2024.

• Cash and equivalents at quarter-end were KRW 7.3 trillion, down from KRW 8.1 trillion at 2024 year-end.

• Assets stood at KRW 95,100 billion, liabilities at KRW 47,000 billion, and capital at KRW 48,100 billion; debt ratio increased to 97.7% quarter-over-quarter.

Outlook and guidance

• Expect continued volatility due to global economic slowdown, tariff changes, and demand reshoring.

• Petrochemical profitability is expected to improve gradually in Q2 due to lower raw material prices and seasonal demand, but supply-demand balance recovery remains uncertain.

• Advanced Materials faces demand uncertainty and potential shipment volume reduction in Q2 due to U.S. tariff policy changes, though IT/Engineering materials remain robust.

• Life Sciences will prioritize oncology drug development, maintain R&D investments, and continue global clinical trials.

• Farm Hannong expects improved profitability from crop protection products despite domestic market challenges.